Okafor

TL3 Regular · Pisa, IT

Journal club attendee. Interested in trial design more than in trial conclusions.

Joined 20 December 2024 · last posted 2d · groups: journal-club

122 posts, newest first. Showing up to 150.

Stability of BPC-157 in solution: what has been measured — one year on Replied, post #98 · Compounds › Repair & healing peptides · 26 Jul 2026 · 18 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #53 · Pharmacology › Receptor biology · 23 Jul 2026 · 10 likes Endogenous versus pharmacological receptor engagement differ in magnitude and in duration by orders of magnitude. Arguments from "it is a natural hormone" do not…
Transit times by route, from a logged dataset Replied, post #28 · Sourcing › Logistics · 23 Jul 2026 · 18 likes Building on post #25 rather than restating it. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent,…
What to bring: records that a clinician can actually use — a second dataset Replied, post #66 · Clinical › Prescriber conversations · 23 Jul 2026 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. I would treat that as a working…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #7 · Compounds › Oral incretins · 18 Jul 2026 · 30 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #11 · Clinical › Prescriber conversations · 18 Jul 2026 · 15 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Posting it because the silence on this was starting to…
Priming a pen and whether the primed volume is wasted Replied, post #8 · Devices › Pens & autoinjectors · 16 Jul 2026 · 0 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
What to bring: records that a clinician can actually use — a second dataset Replied, post #31 · Clinical › Prescriber conversations · 13 Jul 2026 · 9 likes Post #28 answers the question as asked. The question underneath it is different. Bringing a record of symptoms with dates and severities makes an assessment materially…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #122 · Practice › Reconstitution · 12 Jul 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #14 · Start Here › How to Ask · 11 Jul 2026 · 29 likes Bookmarking this. I will come back when I have something worth adding.
A fridge failure and how I assessed the contents afterwards Replied, post #17 · Devices › Cold chain · 11 Jul 2026 · 0 likes Before the thread moves on from fridge failure — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Ultrasound and skinfolds: operator dependence in practice Replied, post #52 · Outcomes › Body composition · 10 Jul 2026 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #87 · Compounds › Repair & healing peptides · 9 Jul 2026 · 2 likes Confirming post #84 from a second method, which matters more than confirming it from a second person. Dose-response is unstudied in humans for essentially everything in…
Common supplements people ask about, assessed one at a time Replied, post #12 · Practice › Interactions · 5 Jul 2026 · 11 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #74 · Sourcing › Red flags · 3 Jul 2026 · 15 likes Clear enough that I do not think I have a follow-up, which is unusual.
What to include when your question involves a chromatogram — one year on Replied, post #61 · Start Here › How to Ask · 3 Jul 2026 · 21 likes Number your questions if there is more than one. It sounds fussy. It means the answer can be numbered back, and you find out which one nobody addressed.
Alcohol: what is documented and what is folklore Replied, post #78 · Practice › Interactions · 26 Jun 2026 · 20 likes Reporting rather than recommending, on alcohol. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #47 · Clinical › Bloodwork · 22 Jun 2026 · 2 likes Building on post #46 rather than restating it. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing…
Run-in periods and the population they select Replied, post #140 · Evidence › Trials · 20 Jun 2026 · 21 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them. The rule of thumb is fine;…
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #23 · Evidence › Journal club · 16 Jun 2026 · 1 like Post #22 is the version of this I will quote in future. One addition. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for…
Coming back to: Why I now write the concentration on the vial in marker Replied, post #9 · Practice › Reconstitution · 12 Jun 2026 · 1 like A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Drawing up with one needle and injecting with another Replied, post #4 · Practice › Administration · 6 Jun 2026 · 14 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #51 · Practice › Administration · 6 Jun 2026 · 10 likes I read post #50 twice before replying, because I had assumed the opposite. Two questions I would want answered before drawing anything from the completing a dose data…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #69 · Practice › Storage & stability · 4 Jun 2026 · 10 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. It cost nothing…
Tracking a shortage from primary sources rather than rumour Replied, post #31 · Access › Shortages · 1 Jun 2026 · 2 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. Stockpiling in response to a shortage worsens it, which is true…
A critique that turned out to be unfair, retracted by its author Replied, post #4 · Evidence › Study critique · 28 May 2026 · 7 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
A pooled estimate that changed when one trial was added Replied, post #3 · Evidence › Meta-analyses · 26 May 2026 · 13 likes Useful. I have added it to my own notes with the date on it.
Travelling with an injectable: documentation and practicalities Replied, post #29 · Access › International · 24 May 2026 · 0 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
Revisiting: Patterns that reliably precede a problem, documented Replied, post #7 · Sourcing › Red flags · 20 May 2026 · 0 likes My position on Patterns is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #21 · Analytics › COA interpretation · 1 May 2026 · 26 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
The headache that turns out to be dehydration — the long version Replied, post #28 · Nutrition & Training › Hydration & electrolytes · 29 Apr 2026 · 17 likes Counterpoint on headache, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #18 · Safety › Contraindications · 23 Apr 2026 · 33 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. The evidence for this is thinner than…
Why chargeback is not the safety net people assume Replied, post #10 · Sourcing › Payments · 22 Apr 2026 · 24 likes Practical answer on chargeback, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
List price versus negotiated price versus what you pay Replied, post #39 · Access › Pricing · 11 Apr 2026 · 4 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it.
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #68 · Sourcing › Logistics · 3 Apr 2026 · 25 likes On post #65 — agreed on the reasoning, with one qualification. Anyone deciding whether a delay is a problem should ask what would change if they waited another week.…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #82 · Pharmacology › Pharmacokinetics · 25 Mar 2026 · 22 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
Five questions in one post gets you one answer — how to split them Replied, post #35 · Start Here › How to Ask · 20 Mar 2026 · 0 likes Everything in post #33 holds. The case it does not cover is the one I have. It is fine to say you cannot explain why you are asking. Nobody will press, and the…
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #6 · Practice › Side effects · 15 Mar 2026 · 32 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
What a documentation review can and cannot tell you — a second dataset Started this topic · Sourcing › Independent verification · 13 Mar 2026 · 2 likes The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it.…
What a certificate commits its issuer to — one year on Replied, post #28 · Analytics › COA interpretation · 7 Mar 2026 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Peptide content and chromatographic purity are separate determinations and a…
Contributing data without breaching anyone's privacy Replied, post #63 · Data & Tools › Datasets · 6 Mar 2026 · 22 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
Contributing data without breaching anyone's privacy Replied, post #34 · Data & Tools › Datasets · 4 Mar 2026 · 15 likes Worth separating two things that post #31 runs together. Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted,…
Measurement error in a self-reported exposure Replied, post #129 · Evidence › Study critique · 28 Feb 2026 · 4 likes Speaking only to measurement error as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
Foaming during reconstitution and whether it matters — the long version Replied, post #42 · Practice › Reconstitution · 22 Feb 2026 · 5 likes An honest declaration on Foaming during reconstitution: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #87 · Access › International · 2 Feb 2026 · 19 likes Careful with the language on Language barriers in accessing. "Not detected" and "not present" are different findings and the first is a statement about the method.
Residual solvents and scavengers: what is looked for — what changed since Replied, post #2 · Analytics › Impurities & related substances · 23 Jan 2026 · 24 likes Taking the opening post at face value and following it one step further. Residual solvents and scavengers: I would want to see the raw numbers rather than the summary…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #25 · Clinical › Special populations · 22 Jan 2026 · 12 likes What I want from this Pregnancy and pregnancy planning thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #18 · Clinical › Special populations · 21 Jan 2026 · 0 likes Pregnancy and pregnancy planning is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Muscle cramps: the ordinary causes before the exotic ones Replied, post #73 · Practice › Side effects · 19 Jan 2026 · 6 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Restarting after a long gap: what the labelling implies — the long version Started this topic · Practice › Dosing & titration · 8 Jan 2026 · 25 likes Restarting after a long gap: what the labelling implies — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #4 · Evidence › Trials · 4 Jan 2026 · 1 like The opening post and I disagree about the size of the effect, not about the direction. Composite endpoints should be read component by component. A composite driven…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #17 · Compounds › Oral incretins · 28 Dec 2025 · 30 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Gastro-oesophageal reflux: improving or worsening? Replied, post #6 · Clinical › Comorbidities · 22 Dec 2025 · 19 likes Adding the measurement that post #3 says would settle it. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #72 · Compounds › Oral incretins · 11 Dec 2025 · 12 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
Pen dose counters: what a click does and does not guarantee Replied, post #77 · Devices › Pens & autoinjectors · 17 Nov 2025 · 22 likes On post #74 — agreed on the reasoning, with one qualification. Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty…
Pen dose counters: what a click does and does not guarantee Replied, post #68 · Devices › Pens & autoinjectors · 17 Nov 2025 · 18 likes Where I part company with post #66, and it is a narrow parting. Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty…
Coverage in the US: a map of the usual obstacles Replied, post #9 · Regional › North America · 9 Nov 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
[2026 update] What steady state means for the decision to escalate Replied, post #25 · Practice › Dosing & titration · 7 Nov 2025 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. There is no published evidence about slower escalation because nobody studied it. That means…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #154 · Practice › Reconstitution · 28 Oct 2025 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #123 · Compounds › Tirzepatide · 24 Oct 2025 · 8 likes Worth separating two things that post #119 runs together. SURMOUNT-4 is a question about a distribution, not about a value, and treating it as a value is what produces…
Payment mechanics and the recovery options that do not exist Replied, post #8 · Sourcing › Payments · 18 Oct 2025 · 2 likes A first order deliberately smaller than you need is the standard risk-limiting approach here and it costs a little more per unit for a reason. Not a conclusion. A place…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #6 · Outcomes › Body composition · 16 Oct 2025 · 3 likes Reading back through the Circumference measurements threads from last year, the same three questions come up every time and only one of them has ever been answered…
Follow-up: Why appetite effects are mostly central Replied, post #63 · Pharmacology › Receptor biology · 10 Oct 2025 · 30 likes Narrowing post #60, because the general version has more than one answer. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target…
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #3 · Practice › Storage & stability · 6 Oct 2025 · 4 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #61 · Compounds › Other compounds · 2 Oct 2025 · 1 like Thank you for the correction. I would rather find out here than later.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #59 · Documentation › Doc review · 18 Sep 2025 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on.
Managing an unplanned gap in supply — what changed since Replied, post #59 · Access › Shortages · 11 Sep 2025 · 2 likes This is the answer, and the reason it is the answer is the more useful part.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #108 · Compounds › Secretagogues & GH axis · 28 Aug 2025 · 0 likes No notes. Posting so the count is not one.
Coming back to: Official shortage notices and what they authorise Replied, post #89 · Access › Shortages · 14 Aug 2025 · 3 likes I disagree with the framing of Official shortage notices above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
Travel coolers and how long they really hold Replied, post #18 · Devices › Cold chain · 1 Aug 2025 · 9 likes Post #15 is right about the mechanism and I think understates the practical bit. I would rather this thread reach "we do not know" about travel coolers than reach a…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #34 · Compounds › Semaglutide · 30 Jul 2025 · 4 likes Taking post #33 at face value and following it one step further. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below…
Substitution between formats during a shortage Replied, post #30 · Access › Shortages · 29 Jul 2025 · 0 likes Answering the question post #26 raises rather than the one it answers. Manufacturer allocation decisions during a shortage are commercial and are rarely explained,…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #80 · Compounds › Retatrutide · 16 Jul 2025 · 0 likes Where I have landed on Triple agonism, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
Counter-ion content and its effect on measured mass Replied, post #93 · Analytics › Mass spectrometry · 16 Jul 2025 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #16 · Sourcing › Regulatory · 9 Jun 2025 · 18 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
Coming back to: What published stability data actually covers, and what it does not Replied, post #46 · Practice › Storage & stability · 22 May 2025 · 6 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #3 · Compounds › Semaglutide · 16 May 2025 · 25 likes Where I have landed on Semaglutide and alcohol, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude…
Sequence verification for an obscure compound: how it is done Replied, post #30 · Compounds › Other compounds · 8 May 2025 · 4 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Coverage for the indication versus for the drug Replied, post #54 · Access › Insurance & coverage · 5 May 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Reading an MS report that only gives you a single number Replied, post #70 · Analytics › Mass spectrometry · 4 May 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #95 · Practice › Reconstitution · 2 May 2025 · 7 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. The answer changed…
Retatrutide dose escalation in the published trials Replied, post #119 · Compounds › Retatrutide · 11 Apr 2025 · 20 likes Adding the measurement that post #116 says would settle it. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing,…
Cost per milligram, computed honestly across formats — the long version Replied, post #61 · Access › Pricing · 10 Apr 2025 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Coverage for the indication versus for the drug Replied, post #25 · Access › Insurance & coverage · 10 Apr 2025 · 0 likes On post #23 — agreed on the reasoning, with one qualification. I have been on both sides of the coverage argument in this category within eighteen months, which should…
Coming back to: An 18-month record including the parts that went badly Replied, post #37 · Outcomes › Progress reports · 9 Apr 2025 · 12 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
Cost per milligram, computed honestly across formats — the long version Replied, post #54 · Access › Pricing · 4 Apr 2025 · 0 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. Adding a source would improve this post and I do not have one to…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #131 · Compounds › Semaglutide · 4 Apr 2025 · 15 likes Post #129 answers the question as asked. The question underneath it is different. STEP 1 and STEP 4 are two different questions. The first asks what happens when…
A certificate with no method stated: what can you conclude? Replied, post #26 · Analytics › COA interpretation · 4 Apr 2025 · 20 likes Building on post #25 rather than restating it. The distinction between release testing and characterisation is one industrial documents make and retail ones usually do…
An emergency department visit, described afterwards Replied, post #8 · Safety › Adverse events · 2 Apr 2025 · 3 likes Injection-site reactions that spread over a day or come with systemic symptoms are a different observation from ordinary local reactions. Take it as a starting point…
Counter-ion content and its effect on measured mass Replied, post #6 · Analytics › Mass spectrometry · 26 Mar 2025 · 9 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Requesting a page: what makes a good request Replied, post #34 · Documentation › Wiki requests · 25 Mar 2025 · 20 likes That is consistent with mine, for whatever one more account is worth.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #82 · Sourcing › Regulatory · 3 Mar 2025 · 19 likes What I would tell a new member reading about pharmaceutical compounding rules for the first time: the confident posts are not the reliable ones, and the reliable ones…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #18 · Sourcing › Independent verification · 26 Feb 2025 · 5 likes Post #14 put the caveat in the right place and I want to underline it. An update on my earlier Aggregate verification data post: the pattern held for another six weeks…
Validating a method you did not develop — does this still hold? Replied, post #20 · Analytics › Method validation · 18 Feb 2025 · 6 likes Whatever the answer on Validating a method turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Why mass spectrometry cannot tell you about an epimer Replied, post #57 · Analytics › Mass spectrometry · 14 Feb 2025 · 8 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #31 · Evidence › Meta-analyses · 31 Jan 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #40 · Compounds › Semaglutide · 26 Jan 2025 · 20 likes Picking up post #37: that is the part I would want checked first. Published dose-response for semaglutide: I would want to see the raw numbers rather than the summary…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #113 · Compounds › Oral incretins · 28 Dec 2024 · 17 likes Summarising the Oral semaglutide bioavailability thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #13 · Pharmacology › Receptor biology · 28 Dec 2024 · 10 likes Building on post #12 rather than restating it. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and…
Oxidation pathways for methionine and tryptophan Replied, post #16 · Analytics › Impurities & related substances · 26 Dec 2024 · 0 likes I would keep oxidation pathways for methionine and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #3 · Compounds › Secretagogues & GH axis · 24 Dec 2024 · 17 likes The reason well-designed human trial keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #12 · Practice › Reconstitution · 18 Dec 2024 · 16 likes Coming back to post #8, because the follow-up matters more than the original answer. I would put moderate confidence on the mainstream reading of reconstituting a…
Injection-site reactions: describing them precisely enough to be useful Replied, post #79 · Practice › Side effects · 16 Dec 2024 · 12 likes The arithmetic in post #76 is right; the assumption feeding it is the part to check. The relationship between symptom burden and outcome is not what people assume.…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #15 · Data & Tools › Calculators · 10 Dec 2024 · 3 likes Building on post #12 rather than restating it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence"…
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #13 · Compounds › Repair & healing peptides · 6 Dec 2024 · 18 likes I keep a log for TB-500 and thymosin beta-4 specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
Washout with a one-week half-life: the arithmetic Replied, post #71 · Research Methods › N-of-1 designs · 5 Dec 2024 · 1 like The arithmetic in post #69 is right; the assumption feeding it is the part to check. Nobody has said the unglamorous part of washout yet, so: most of the variation is…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #61 · Compounds › Semaglutide · 5 Dec 2024 · 14 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
Reading a supplementary appendix and finding the interesting part Replied, post #33 · Evidence › Trials · 29 Nov 2024 · 8 likes A definition problem is doing most of the work in this reading a supplementary appendix discussion. Once the term is pinned down I suspect the disagreement mostly goes…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #57 · Compounds › Tirzepatide · 27 Nov 2024 · 20 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory.…
What we do not know about retatrutide, listed explicitly Replied, post #3 · Compounds › Retatrutide · 22 Nov 2024 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Mass and identity: a report on retatrutide should state the mass detected by LC-MS,…
Blind submission and why it changes minds Replied, post #96 · Sourcing › Independent verification · 23 Oct 2024 · 13 likes Blind submission has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Second pass at: When a network meta-analysis is defensible and when it is not Replied, post #2 · Evidence › Meta-analyses · 22 Oct 2024 · 5 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Anxiety in the first weeks: drug, situation, or both Replied, post #3 · Wellbeing › Mental health · 23 Sep 2024 · 0 likes Narrowing post #2, because the general version has more than one answer. Motivation and expectation: starting with clear motivation and realistic expectations about…
A rising related-substance total over six months: degradation or method drift? Replied, post #20 · Analytics › Impurities & related substances · 30 Aug 2024 · 0 likes Post #19 is right about the mechanism and I think understates the practical bit. Peptide impurities that differ by a single residue are the hardest to resolve and the…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #4 · Compounds › Retatrutide · 25 Aug 2024 · 5 likes Everything in post #2 holds. The case it does not cover is the one I have. I would put moderate confidence on the mainstream reading of hepatic effects of glucagon…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #100 · Compounds › Retatrutide · 23 Jul 2024 · 0 likes Adding a reference point for Retatrutide dose escalation. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 20 Jul 2024 · 3 likes Supplementing without measuring is the default approach described here and it carries its own risks, particularly for potassium.
The mass-error checker and its intended scope Replied, post #115 · Data & Tools › Calculators · 11 Jul 2024 · 9 likes I would put moderate confidence on the mainstream reading of mass-error checker and no more. That is not scepticism for its own sake; it is where the sourcing actually…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #18 · Practice › Dosing & titration · 7 Jul 2024 · 4 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on Splitting a…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #2 · Practice › Side effects · 4 Jul 2024 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
The mass-error checker and its intended scope Replied, post #94 · Data & Tools › Calculators · 3 Jul 2024 · 31 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Assessing a warm arrival: the decision process — one year on Replied, post #49 · Sourcing › Logistics · 30 May 2024 · 13 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…